Wednesday, 08 January 2025 06:45 AM
Company Update
Germany's transcutaneous monitors market is set to grow at a 5.8% CAGR (2025-2035), leading Western Europe. Advanced healthcare infrastructure, government support, and innovation drive this growth, focusing on quality and connectivity.
NEWARK, DE / ACCESSWIRE / January 8, 2025 / The global market for transcutaneous monitors is poised for significant growth over the next decade, with sales estimated to rise from USD 455.9 million in 2025 to USD 694.6 million by 2035, marking a compound annual growth rate (CAGR) of 4.3%. In 2024, the market generated revenue of USD 437.1 million, reflecting steady demand and expanding adoption of these critical medical devices.
The transcutaneous monitors market has been displaying a trend of technological advancements over the last decade, and the introduction of automated patient monitoring systems such as the novel multichannel transcutaneous monitors is expected to drive market growth over the next seven years.
Due to the high demand for sensibly operated patient monitoring systems for ease of collection of patient dynamics and the collation of patient data for display to the physicians in case of abrupt emergency response, the development of transcutaneous monitors is gaining traction.
With the non-invasive monitoring method of patient oxygenation data through the incorporation of sensors for blood gas diffusion dynamics, the transcutaneous monitors market will emerge as smart monitoring systems over the projected forecast period
What are the Key Opportunities for Transcutaneous Monitors Manufacturers?
The opportunistic growth of the transcutaneous monitors market is associated with the property of incorporated auto calibration property of the monitors to ensure an accurate and stable device output. The requisites for adequate maintenance and calibration after specified intervals of time can be time-consuming and a cost-incurring process.
However, the introduction of automated transcutaneous monitors and defining their preference over manually calibrated transcutaneous monitors is set to project a lucrative growth in the rate of adoption of transcutaneous monitors over the forecast period.
The introduction of multichannel transcutaneous monitors has further presented a unique approach to market penetration for the key players in the transcutaneous monitors market. The multichannel transcutaneous monitors are capable of coupling with a multitude variation of sensors which are primarily applicable to patient monitoring systems.
With the display of multiple factor-associated outcomes related to patient care, multichannel transcutaneous monitors present a rising opportunity for manufacturers in the transcutaneous monitors market. Additionally, the innovative developments in new device integration such as the induction of IR and wireless technologies by chief manufacturers are posing a rise in the potential of adoption of transcutaneous monitors in developed economies. However, the factor of the cost associated with the manufacturing capabilities and technology integration into the current systems may be a hurdle for the rapid emergence of novel transcutaneous patient monitoring devices.
But, the applications of these devices in a wide range of processes, such as respiratory care, blood gas monitoring, wound healing, measurement of amputation level, and diagnostic procedures in vascular ischemia and diabetes among others have subjected the market to a potential track to the evolution of transcutaneous monitoring devices for optimized patient output.
Thus, the growing applications of transcutaneous monitors in the above-mentioned applications are likely to advance the sales revenue growth of major product manufacturers in the transcutaneous monitors market over the forecast period.
What are the Factors Restraining Demand for Transcutaneous monitors?
Although the applications of transcutaneous monitors are gaining traction, pulse oximeters are widely being replaced as a preference over transcutaneous monitoring for basic vital analysis for patients. Moreover, stringent regulatory guidelines and the approval of novel medical devices in various regions may act as one of the chief restrictive factors for the penetration of emerging manufacturing players in the transcutaneous monitors market.
Transcutaneous monitors are classified under the class II medical device category. Even though there is a form 510(K) exclusion for class II devices, the market approval of the new medical device products as well as sub-optimal outcomes in clinical trials may lead to restricting the revenue growth of emerging companies in the transcutaneous monitors market.
Additionally, the factors associated with the lack of reimbursement policies in developing regions have imposed a restrictive impact on the growth of the adoption of transcutaneous monitors. Moreover, the reimbursement scenario in the developed regions with established healthcare systems is paving the way for the formulation of guidelines and policies of reimbursement associated with the procedures which entail the applications of transcutaneous monitoring devices. The developmental scenario of reimbursement in developed countries is thus a complex process and is currently under advancement, as per the regulations guiding the intended use of particular patient monitoring medical devices.
These factors are thus associated with the low share of the transcutaneous monitors market, owing to the low investment activities by major investors, as well as foreign ventures, which directly translates to a major restraint in the growth of the transcutaneous monitors market.
Key Takeaways: Transcutaneous Monitors Market
Market Growth: Global sales of transcutaneous monitors are projected to grow from USD 455.9 million in 2025 to USD 694.6 million by 2035, with a CAGR of 4.3% during the forecast period (2025-2035). Revenue in 2024 was USD 437.1 million.
Regional Insights:
United States: Forecasted to achieve a Value CAGR of 4.0% (2025-2035).
Germany: Expected to grow at a Value CAGR of 5.1% (2025-2035).
China: Leading growth with a projected Value CAGR of 5.8% (2025-2035).
France: Anticipated to expand at a Value CAGR of 5.5% (2025-2035).
India: Highest growth among regions with a Value CAGR of 6.3% (2025-2035).
Spain: Estimated to achieve a Value CAGR of 4.9% (2025-2035).
Australia & New Zealand: Predicted to grow at a Value CAGR of 5.2% (2025-2035).
South Korea: Projected to record a Value CAGR of 5.9% (2025-2035).
Growth Drivers: Rising adoption of transcutaneous monitors across healthcare facilities, technological advancements, and increasing prevalence of conditions requiring continuous monitoring.
This data underscores a robust outlook for the transcutaneous monitors market, with substantial growth across key regions worldwide.
"The transcutaneous monitors market is evolving rapidly due to their critical role in neonatal care. Their ability to provide continuous, real-time data has revolutionized monitoring practices in NICUs. As healthcare providers increasingly prioritize non-invasive and patient-friendly solutions, transcutaneous monitors are becoming the standard of care for premature and critically ill neonates. This market is expected to see further advancements in device accuracy and comfort, further driving adoption globally," says Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI) analyst.
Growing Market Interest: Explore Comprehensive Insights and Trends with Our Detailed Report!
https://www.futuremarketinsights.com/reports/transcutaneous-monitors-market
Competitive Landscape:
Market players are adopting various strategies to maintain a competitive edge, including product differentiation through innovative formulations and forming strategic partnerships with healthcare providers for efficient distribution. Additionally, these companies are prioritizing collaborations to strengthen their product portfolios and expand their presence in global markets.
Recent Developments in the Transcutaneous Monitors Market:
July 2024: GE HealthCare announced an agreement to acquire Intelligent Ultrasound Group PLC's clinical artificial intelligence (AI) software business for approximately USD 51 million. Intelligent Ultrasound specializes in integrated AI-driven image analysis tools that enhance ultrasound technology, improving workflows and usability for clinicians and patients alike.
February 2024: GE HealthCare and Biofourmis entered a strategic collaboration to enhance continuity of care by enabling safe, effective, and accessible care at home. This partnership combines the expertise of both companies to deliver scalable and innovative care-at-home solutions, supporting patients beyond the hospital setting.
Key Players of Transcutaneous Monitors Market:
GE Healthcare
Philips Healthcare
Hill Rom Services Inc.
Medtronic
Radiometer Medical Aps
SenTec AG
Perimed AB
Criticare Technologies, Inc.
Masimo
Perimed AB
Criticare Technologies, Inc.
Key Segments of Transcutaneous Monitors Market:
By Channel Type:
In terms of channel type, the industry is divided into- single channel and multi-channel.
By End User:
In terms of end user, the industry is segregated into- Hospitals, ambulatory surgical centers, diagnostic centers, and home care settings.
By Region:
Key countries of North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia and Middle East and Africa (MEA) have been covered in the report.
Authored By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI's Related Ongoing Coverage on Healthcare Market Insights Domain:
The global sleep apnea diagnostic systems market size has reached a valuation of US$ 4.81 billion in 2023, with a projected CAGR of 6.8% from 2023 to 2033. By 2033, the market is anticipated to reach US$ 9.27 billion.
The multi-parameter patient monitoring market share is anticipated to be worth US$ 4.8 billion in 2023. It is expected to reach US$ 7.2 billion by 2033, registering a 4.0% CAGR between 2023 and 2033.
The global sleep aid devices market demand is poised for significant expansion, with projections indicating an impressive surge from approximately USD 68354.36 Million in 2022 to an astounding USD 133211.98 Million by 2032. This growth trajectory highlights a Compound Annual Growth Rate (CAGR) of 6.9%.
The global home sleep apnea testing market growth are estimated to be worth USD 712.3 million in 2025 and are anticipated to reach a value of USD 966.1 million by 2035. Sales are projected to rise at a CAGR of 3.1% over the forecast period between 2025 and 2035.
The global surgical booms market trends is estimated to be worth USD 317.1 million in 2025 and anticipated to reach a value of USD 477.7 million by 2035. Sales are projected to rise at a CAGR of 4.3% over the forecast period between 2025 and 2035.
The global vacuum mixing devices market outlook is estimated to be worth USD 169.5 million in 2025 and anticipated to reach a value of USD 214.9 million by 2035. Sales are projected to rise at a CAGR of 2.4% over the forecast period between 2025 and 2035.
The pancreatic stone protein testing market overview is estimated to reach USD 2.2 billion in 2024. It is anticipated to grow at a CAGR of 2.3% during the assessment period 2024 to 2034 and reach a value of USD 2.8 billion by 2034.
The global cardiac surgery devices market strategies is estimated to be worth USD 1.8 billion in 2024 and is projected to grow at a CAGR of 3.7%, reaching USD 2.5 billion by 2034.
The global lacrimal devices market development are estimated to be worth USD 32.1 million in 2025 and anticipated to reach a value of USD 57.0 million by 2035. Sales are projected to rise at a CAGR of 5.9% over the forecast period between 2025 and 2035.
The global knotless tissue control devices market opportunity are estimated to be worth USD 494.4 million in 2025 and are anticipated to reach a value of USD 728.6 million by 2035. Sales are projected to rise at a CAGR of 2.7% over the forecast period between 2025 and 2035.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: [email protected]
Website: https://www.futuremarketinsights.com
LinkedIn | Twitter | Blogs | YouTube
SOURCE: Future Market Insights Inc.